Ronald Gardner, MD
Orthopaedic Surgery · Fort Myers, FLNPI 1255334488
Payments from drug & device makers
Across 191 payments — averaging $518.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shalby Advanced Technologies, Inc.$49K
- Tracpatch Health, Inc$21K
- Aesculap Implant Systems, LLC$16K
- Avanos Medical$7K
- Curonix LLC$1K
- Microport Orthopedics Inc$912
- plus $4K from 30 others
Across 1 payment — averaging $28,050 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ASA Srl$28K
What the payments were for
- Consulting fees$73,95775%
- Speaking & faculty fees$12,05712%
- Travel & lodging$5,3405%
- Food & beverage$7,5358%
- Education$1210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shalby Advanced Technologies, Inc. | 43 | $48,901 |
| Tracpatch Health, Inc | 16 | $21,159 |
| Aesculap Implant Systems, LLC | 33 | $15,919 |
| Avanos Medical | 7 | $6,578 |
| Curonix LLC | 9 | $1,426 |
| Microport Orthopedics Inc | 6 | $912 |
| Si-bone, Inc. | 11 | $626 |
| Stryker | 5 | $372 |
| Medtronic | 3 | $315 |
| Linkbio Corp | 4 | $278 |
| Zimmer Biomet | 3 | $273 |
| Pacira Pharmaceuticals Incorporated | 3 | $253 |
| Medical Device Business Services, Inc. | 2 | $223 |
| Orthalign Inc | 2 | $194 |
| Aesculap Biologics, LLC | 1 | $153 |
| Molnlycke Health Care US, LLC | 3 | $152 |
| Johnson & Johnson(2 entities) | 2 | $142 |
| Vertex | 1 | $125 |
| Ferring Pharmaceuticals Inc. | 7 | $111 |
| Amgen(2 entities) | 5 | $108 |
| Orthofix Medical, Inc. | 1 | $105 |
| Merz North America, Inc. | 1 | $100 |
| Pacira Therapeutics, Inc. | 6 | $92 |
| Catalyst Orthoscience | 1 | $89 |
| Heraeus Medical, LLC. | 1 | $69 |
| Smith+Nephew | 1 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Channel-markers Medical LLC | 1 | $39 |
| Vertos Medical, Inc. | 1 | $37 |
| Fidia Pharma USA Inc. | 3 | $31 |
| MVP Orthopedics Inc | 1 | $26 |
| Naviswiss, Inc. | 1 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Orthogenrx Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CONSENSUS KNEE SYSTEM$78,882
- CKS- Vitalite$41,836
- CONSENSUS HIP SYSTEM$25,732
- COREHIP PRIMARY$8,002
- COLUMBUS CR$7,336
- ON-Q$6,493
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,225
- MPO Hip System$842
- CKS 3.0$546
- iFuse Implant$462
- Taperset Reduced Distal Profile$342
- EXPAREL$241
- Taperset Hip System$182
- Acetabular Shell$182
- ClosureFast$169
- NOVOCART 3D$153
- TRITANIUM$146
- MAKO$146
- TRIATHLON$146
- Persona$145
How this compares
$99,009 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 740 | $19,151 |
| XareltoRivaroxaban | 13 | $3,227 |
| Cephalexin | 578 | $2,521 |
| Oxycodone Hcl | 325 | $2,239 |
| Allopurinol | 229 | $1,777 |
| Meloxicam | 503 | $1,420 |
| Tramadol Hcl | 213 | $1,374 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $1,180 |
| Ondansetron OdtOndansetron | 161 | $1,116 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 136 | $765 |
| Fentanyl | 14 | $687 |
| Gabapentin | 76 | $611 |
| Cyclobenzaprine Hcl | 76 | $473 |
| Clindamycin Hcl | 110 | $462 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $377 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $142 | $3,22713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Other orthopaedic surgery in Fort Myers
- William HodgeFort Myers$1.1M
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$35M
- Mark FrankleTemple Terrace$31.4M
- David WatsonTemple Terrace$21M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Martin RocheFt. Lauderdale$7.3M
- Robert SantrockFernandina Beach$7.3M
- Steven LyonsTampa$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.